Chiron Diagnostics has 510(k) pending for ACS:Centaur automated chemiluminescence analyzer.
This article was originally published in The Gray Sheet
Executive Summary
CHIRON DIAGNOSTICS ACS:CENTAUR ANALYZER 510(k) PENDING at FDA, the company says. Chiron unveiled the "next-generation" automated, chemiluminescence analyzer July 29 at the American Association of Clinical Chemistry meeting in Chicago; the firm expects to begin marketing through its direct sales force next spring in the U.S. and Europe.